United States · Law · S
S. 2554 (115th)
Patient Right to Know Drug Prices Act
Introduced
14 March 2018
Last action
10 October 2018 · President
Status
Became Public Law No: 115-263.
Sponsors
Sen. Collins, Susan M. [R-ME], Sen. McCaskill, Claire [D-MO], Sen. Barrasso, John [R-WY], Sen. Stabenow, Debbie [D-MI], Sen. Cassidy, Bill [R-LA], Sen. Smith, Tina [D-MN], Sen. Donnelly, Joe [D-IN], Sen. Feinstein, Dianne [D-CA], Sen. Murkowski, Lisa [R-AK], Sen. Menendez, Robert [D-NJ], Sen. Baldwin, Tammy [D-WI], Sen. Kennedy, John [R-LA], Sen. Hassan, Margaret Wood [D-NH], Sen. Blumenthal, Richard [D-CT], Sen. Wicker, Roger F. [R-MS], Sen. Capito, Shelley Moore [R-WV], Sen. Heitkamp, Heidi [D-ND], Sen. Fischer, Deb [R-NE], Sen. Alexander, Lamar [R-TN], Sen. Boozman, John [R-AR], Sen. King, Angus S., Jr. [I-ME], Sen. Brown, Sherrod [D-OH], Sen. Heinrich, Martin [D-NM], Sen. Grassley, Chuck [R-IA], Sen. Udall, Tom [D-NM], Sen. Klobuchar, Amy [D-MN]
Subjects
Healthcare
Source updated
21 April 2025
Summary
Patient Right to Know Drug Prices Act (Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.) (Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 March 2018
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
14 March 2018
Introduced
Introduced in Senate
Source: IntroReferral
25 July 2018
Reported
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Source: Committee
31 July 2018
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 549.
Source: Calendars
31 July 2018
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Source: Committee
31 July 2018
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Source: Committee
17 September 2018
Vote
Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 98 - 2. Record Vote Number: 209.
Source: Floor
17 September 2018
Floor
Measure laid before Senate by unanimous consent. (consideration: CR S6179-6180)
Source: Floor
18 September 2018
Floor
Message on Senate action sent to the House.
Source: Floor
20 September 2018
Floor
Held at the desk.
Source: Floor
20 September 2018
Floor
Received in the House.
Source: Floor
25 September 2018
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
25 September 2018
Passed
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8795-8796)
Source: Floor
25 September 2018
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8795-8796)
Source: Floor
25 September 2018
Floor
DEBATE - The House proceeded with forty minutes of debate on S. 2554.
Source: Floor
25 September 2018
Floor
Considered under suspension of the rules. (consideration: CR H8795-8799)
Source: Floor
25 September 2018
Floor
Mr. Carter (GA) moved to suspend the rules and pass the bill.
Source: Floor
1 October 2018
Floor
Presented to President.
Source: Floor
1 October 2018
President
Presented to President.
Source: President
10 October 2018
Became law
Became Public Law No: 115-263.
Source: President
10 October 2018
Became law
Signed by President.
Source: BecameLaw
10 October 2018
President
Signed by President.
Source: President
Votes
17 September 2018 · Bill Passed · On Passage of the Bill S. 2554 · Bill Passed · Official source
Yes 98 · No 2 · Abstain — · Absent/not voting 0
- Sen. Klobuchar, Amy [D-MN]Yea
- Sen. King, Angus S., Jr. [I-ME]Yea
- Sen. Cardin, Benjamin L. [D-MD]Yea
- Sen. Sasse, Ben [R-NE]Yea
Showing the first 4 recorded positions. Vote totals above are complete.
Versions
- Enrolled Bill · — · Download file
- Public Law · 10 October 2018 · Download file
- Engrossed in Senate · 17 September 2018 · Download file
- Reported to Senate · 31 July 2018 · Download file
- Introduced in Senate · 14 March 2018 · Download file
Documents
11 official files
Enrolled Bill (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (text)
Public Law · EN · 10 October 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (PDF)
Public Law · EN · 10 October 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law
summary · EN · 10 October 2018
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in Senate (text)
Engrossed in Senate · EN · 17 September 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 17 September 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to Senate (text)
Reported to Senate · EN · 31 July 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to Senate (PDF)
Reported to Senate · EN · 31 July 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 14 March 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (PDF)
Introduced in Senate · EN · 14 March 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Collins, Susan M. [R-ME] · R · Sponsor
- Sen. McCaskill, Claire [D-MO] · D · Sponsor
- Sen. Barrasso, John [R-WY] · R · Sponsor
- Sen. Stabenow, Debbie [D-MI] · D · Sponsor
- Sen. Cassidy, Bill [R-LA] · R · Sponsor
- Sen. Smith, Tina [D-MN] · D · Cosponsor
- Sen. Donnelly, Joe [D-IN] · D · Cosponsor
- Sen. Feinstein, Dianne [D-CA] · D · Cosponsor
- Sen. Murkowski, Lisa [R-AK] · R · Cosponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Sen. Baldwin, Tammy [D-WI] · D · Cosponsor
- Sen. Kennedy, John [R-LA] · R · Cosponsor
- Sen. Hassan, Margaret Wood [D-NH] · D · Cosponsor
- Sen. Blumenthal, Richard [D-CT] · D · Cosponsor
- Sen. Wicker, Roger F. [R-MS] · R · Cosponsor
- Sen. Capito, Shelley Moore [R-WV] · R · Cosponsor
- Sen. Heitkamp, Heidi [D-ND] · D · Cosponsor
- Sen. Fischer, Deb [R-NE] · R · Cosponsor
- Sen. Alexander, Lamar [R-TN] · R · Cosponsor
- Sen. Boozman, John [R-AR] · R · Cosponsor
- Sen. King, Angus S., Jr. [I-ME] · I · Cosponsor
- Sen. Brown, Sherrod [D-OH] · D · Cosponsor
- Sen. Heinrich, Martin [D-NM] · D · Cosponsor
- Sen. Grassley, Chuck [R-IA] · R · Cosponsor
- Sen. Udall, Tom [D-NM] · D · Cosponsor
- Sen. Klobuchar, Amy [D-MN] · D · Cosponsor
- · sshr00 · Standing
Related records
- related to → Know the Lowest Price Act of 2018
- related to ← Patient Right to Know Drug Prices Act
- related to ← Know the Cost Act of 2018
- amends ← To limit application of the gag clause to self-insured group health plans.
Related across the Repo ecosystem
Direct relationships are identifier-backed. Topic context means shared TopicMembership — not a citation and not causation.
Direct relationships
- Legal framework · Patient Right to Know Drug Prices Act · S. 2554 (115th) · US
- Identifier matchPROJECTS_FROM
Same us record 115-s-2554 projected from PoliticalRepo US row.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/2554
- Open data entity: https://api.congress.gov/v3/bill/115/s/2554
- us · 115-s-2554 · source updated 21 April 2025